Caxton Associates (New York)’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,240	Closed	-$392K	–	436
2021 Q2	$392K	Buy	+4,240	New	+$392K	0.04%	219